ArticleCancers2021

The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma.

Xing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.